Morgan Stanley Sees Good Things Ahead for St. Jude Medical Despite Challenges

By: via Benzinga
In a report published Thursday, Morgan Stanley analyst David R. Lewis reiterated an Overweight rating and $75.00 price target on St. ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.